Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Telling founders no Board meeting etiquette|Michael Luciani,Managing Partner,Climate Capital
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Managing Partner at Climate Capital.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Brunswick Corporation, the leading marine group globally, renowned for its iconic brands including Mercury Marine, Boston Whaler, Bayliner, and Sea-Ray.|David M. Foulkes holds the position of Chief Executive Officer & Director at Brunswick Corp.
00:10:00
Legal Insights: Panel with Evan Chesler and NYU Law Professors | Evan R. Chesler - RETIRED PARTNER of Cravath, Swaine & Moore LLP
00:10:00
The Investor Perspective- From Start to Scale' with Caryn Marooney|Chetan Puttagunta,investor,Benchmark
00:10:00
Edison's head of investment companies, Rob Murphy, met with Roderick Wong, managing director of RTW Investments, to discuss RTW Biotech's strategic advancements and investment opportunities.
00:10:00
invests across categories and geographies at the pre seed and seed stages|Andrea Funsten,Managing Partner,Basecamp Fund
00:10:00
Navigating U.S. Securitized Markets: Active Strategies in an Uncertain Rate Environment | John Kerschner - Head of US Securitised Products | Portfolio Manager of Janus Henderson Investors
00:10:00
Equity Strategies for Growth: A Deep Dive into the Foord Equity Fund | Roland Rousseau - Equity Strategist, Absa
00:10:00
Growth and profitability must be met with good governance says venture capitalist|Yinglan Tan,Founding Managing Partner,Insignia Ventures Partners
00:10:00
EEI interviews NorthWestern Energy's President and CEO Bob Rowe to explore his insights on the future of technology, regulation, and energy trends.
00:10:00
Buxton Resources: Advancing High-Grade Graphite and Copper Projects in Western Australia
00:10:00
investments in technology companies with conviction since 1970|Saar Gur,General Partner,CRV
00:10:00
Inflation Stalemate and Its Impact on Federal Reserve Rate Cuts |Russell Price, Chief Economist , Ameriprise Financial Inc.